(Q38227727)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25008043%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

Microglia and inflammation: conspiracy, controversy or control? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25008043%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25008043%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Leonor Miller-Fleming

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25008043%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Teresa F Pais

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25008043%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

publication date

10 July 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25008043%20AND%20SRC:MED&resulttype=core&format=json

Cellular and Molecular Life Sciences

9 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25008043%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25008043%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25008043%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

3969-3985

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25008043%20AND%20SRC:MED&resulttype=core&format=json

A lineage of myeloid cells independent of Myb and hematopoietic stem cells

9 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

ATP mediates rapid microglial response to local brain injury in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Fate mapping analysis reveals that adult microglia derive from primitive macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Does neuroinflammation fan the flame in neurodegenerative diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Microglia as modulators of cognition and neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

The mononuclear phagocyte system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Local self-renewal can sustain CNS microglia maintenance and function throughout adult life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Reactive microgliosis engages distinct responses by microglial subpopulations after minor central nervous system injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Brain macrophage activation in murine cerebral malaria precedes accumulation of leukocytes and CD8+ T cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

TGF-β superfamily gene expression and induction of the Runx1 transcription factor in adult neurogenic regions after brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Microglia: active sensor and versatile effector cells in the normal and pathologic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Microglial phenotype: is the commitment reversible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Alternative activation of macrophages: an immunologic functional perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Activation of microglial cells by beta-amyloid protein and interferon-gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Necrotic neurons enhance microglial neurotoxicity through induction of glutaminase by a MyD88-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Amyloid-β Protein Oligomer at Low Nanomolar Concentrations Activates Microglia and Induces Microglial Neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Integrated expression profiles of mRNA and miRNA in polarized primary murine microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

IL-4-induced selective clearance of oligomeric beta-amyloid peptide(1-42) by rat primary type 2 microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Toll-like receptor (TLR) and inflammasome actions in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

The TREM receptor family and signal integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Heterogeneous expression of the triggering receptor expressed on myeloid cells-2 on adult murine microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Pattern recognition by TREM-2: binding of anionic ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

The surface-exposed chaperone, Hsp60, is an agonist of the microglial TREM2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Mutations in TREM2 lead to pure early-onset dementia without bone cysts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Heterogeneity of presenile dementia with bone cysts (Nasu-Hakola disease): three genetic forms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

TREM2 in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Protective effects of microglia in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Identification of a microglia phenotype supportive of remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Siglecs and their roles in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Siglecs and immune regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Cloning and characterization of human Siglec-11. A recently evolved signaling molecule that can interact with SHP-1 and SHP-2 and is expressed by tissue macrophages, including brain microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Alleviation of neurotoxicity by microglial human Siglec-11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Microglial CD33-related Siglec-E inhibits neurotoxicity by preventing the phagocytosis-associated oxidative burst

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

CD200 ligand receptor interaction modulates microglial activation in vivo and in vitro: a role for IL-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Inhibition of CD200R1 expression by C/EBP β in reactive microglial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Dok2 mediates the CD200Fc attenuation of Aβ-induced changes in glia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Down-regulation of the macrophage lineage through interaction with OX2 (CD200)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Elevated neuronal expression of CD200 protects Wlds mice from inflammation-mediated neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: a potential mechanism leading to chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Microglia, seen from the CX3CR1 angle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Fractalkine attenuates excito-neurotoxicity via microglial clearance of damaged neurons and antioxidant enzyme heme oxygenase-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Control of microglial neurotoxicity by the fractalkine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Regulation of adaptive immunity by the fractalkine receptor during autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Suppression of central chemokine fractalkine receptor signaling alleviates amyloid-induced memory deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Modulation of immune cell signalling by the leukocyte common tyrosine phosphatase, CD45.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Immunoreactivity of CD45, a protein phosphotyrosine phosphatase, in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

CD45RB is a novel molecular therapeutic target to inhibit Abeta peptide-induced microglial MAPK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Neuronal expression of CD22: novel mechanism for inhibiting microglial proinflammatory cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Regulation of Ly49D/DAP12 signal transduction by Src-family kinases and CD45

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Astrocytes are GABAergic cells that modulate microglial activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Neurotransmitters and microglial-mediated neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Mammalian nicotinic acetylcholine receptors: from structure to function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Activation of alpha7 nicotinic acetylcholine receptor by nicotine selectively up-regulates cyclooxygenase-2 and prostaglandin E2 in rat microglial cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Effects of norepinephrine on rat cultured microglial cells that express alpha1, alpha2, beta1 and beta2 adrenergic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Inhibition of microglial inflammatory responses by norepinephrine: effects on nitric oxide and interleukin-1beta production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Neurotrophins inhibit major histocompatibility class II inducibility of microglia: involvement of the p75 neurotrophin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Brain-derived neurotrophic factor induces sustained elevation of intracellular Ca2+ in rodent microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Neurotrophins regulate the function of cultured microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Downregulation of inducible nitric oxide synthetase by neurotrophin‐3 in microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Endogenous transforming growth factor-beta promotes quiescence of primary microglia in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Potent anti-inflammatory and neuroprotective effects of TGF-beta1 are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

TGF-beta1 upregulates CX3CR1 expression and inhibits fractalkine-stimulated signaling in rat microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

The genomic landscapes of inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

NF-κB, the first quarter-century: remarkable progress and outstanding questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Role of microglial IKKbeta in kainic acid-induced hippocampal neuronal cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Microglia induce motor neuron death via the classical NF-κB pathway in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Neurotoxic activation of microglia is promoted by a nox1-dependent NADPH oxidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Redox regulation of glial inflammatory response to lipopolysaccharide and interferongamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

The transcription factor Nrf2 is a therapeutic target against brain inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Transcription factor Nrf2 suppresses LPS-induced hyperactivation of BV-2 microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Dysregulated microRNAs in amyotrophic lateral sclerosis microglia modulate genes linked to neuroinflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α-PU.1 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Translating the Histone Code

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Acetylation and deacetylation of non-histone proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Histone deacetylase (HDAC) inhibitors reduce the glial inflammatory response in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Histone deacetylase inhibition modulates kynurenine pathway activation in yeast, microglia, and mice expressing a mutant huntingtin fragment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

The diversity of histone versus nonhistone sirtuin substrates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

SIRT2 regulates NF-κB dependent gene expression through deacetylation of p65 Lys310

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

The regulation of SIRT2 function by cyclin-dependent kinases affects cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Engineered stem cell-derived microglia as therapeutic vehicle for experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Celecoxib attenuates systemic lipopolysaccharide-induced brain inflammation and white matter injury in the neonatal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

The promise of minocycline in neurology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Minocycline: stain devil?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Clinical potential of minocycline for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Minocycline blocks nitric oxide-induced neurotoxicity by inhibition p38 MAP kinase in rat cerebellar granule neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Minocycline prevents glutamate-induced apoptosis of cerebellar granule neurons by differential regulation of p38 and Akt pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE-1 in a transgenic model of Alzheimer's disease-like amyloid pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Inhibition of microglial activation protects hippocampal neurogenesis and improves cognitive deficits in a transgenic mouse model for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Minocycline affects microglia activation, Abeta deposition, and behavior in APP-tg mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Inhibition of autoimmune encephalomyelitis by a tetracycline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Prospects for minocycline neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Suppression of microglial inflammatory activity by myelin phagocytosis: role of p47-PHOX-mediated generation of reactive oxygen species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Visualization and genetic modification of resident brain microglia using lentiviral vectors regulated by microRNA-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Anti-inflammatory therapy in chronic disease: challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Tumor necrosis factor-alpha expression in ischemic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Intranigral lentiviral delivery of dominant-negative TNF attenuates neurodegeneration and behavioral deficits in hemiparkinsonian rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

CD200 fusion protein decreases microglial activation in the hippocampus of aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Selective targeting of microglia by quantum dots.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Wild-type microglia arrest pathology in a mouse model of Rett syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Brain-specific gene expression by immortalized microglial cell-mediated gene transfer in the mammalian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Distribution of the Immune Inhibitory Molecules CD200 and CD200R in the Normal Central Nervous System and Multiple Sclerosis Lesions Suggests Neuron-Glia and Glia-Glia Interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Inflammatory Signals Induce Neurotrophin Expression in Human Microglial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1670-8

Elevated expression of fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) in the dorsal root ganglia and spinal cord in experimental autoimmune encephalomyelitis: implications in multiple sclerosis-induced neuropathic pain.

21 January 2018

1 reference

12 December 2020

Pilot study of minocycline in relapsing-remitting multiple sclerosis

1 reference

12 December 2020

Pharmacotherapeutics of the newer tetracyclines

1 reference

12 December 2020

miR-155 modulates microglia-mediated immune response by down-regulating SOCS-1 and promoting cytokine and nitric oxide production

1 reference

12 December 2020

Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared

1 reference

12 December 2020

Potential of tetracyclines to modify cartilage breakdown in osteoarthritis

1 reference

12 December 2020

Protective effects of an anti-inflammatory cytokine, interleukin-4, on motoneuron toxicity induced by activated microglia

1 reference

12 December 2020

CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells

1 reference

12 December 2020

Hypothalamic programming of systemic ageing involving IKK-β, NF-κB and GnRH

1 reference

12 December 2020

Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1)

1 reference

12 December 2020

Microglial calcium signal acts as a rapid sensor of single neuron damage in vivo

1 reference

12 December 2020

The endotoxin-induced neuroinflammation model of Parkinson's disease.

1 reference

12 December 2020

Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a cAMP-dependent pathway

1 reference

12 December 2020

Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia

1 reference

12 December 2020

CD45 opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activated protein kinase

1 reference

12 December 2020

The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study

1 reference

12 December 2020

Pharmacologic suppression of neuronal oxidative damage and dendritic degeneration following direct activation of glial innate immunity in mouse cerebrum

1 reference

12 December 2020

Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia

1 reference

12 December 2020

Cholinergic agonists increase intracellular Ca2+ in cultured human microglia

1 reference

12 December 2020

Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease.

1 reference

12 December 2020

Microgliosis: the questions shape the answers

1 reference

12 December 2020

Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-beta.

1 reference

12 December 2020

Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease.

1 reference

12 December 2020

Endogenous transforming growth factor beta 1 suppresses inflammation and promotes survival in adult CNS

1 reference

12 December 2020

Vasoactive intestinal peptide protects against beta-amyloid-induced neurodegeneration by inhibiting microglia activation at multiple levels

1 reference

12 December 2020

Neuroprotective role of IL-4 against activated microglia

1 reference

12 December 2020

Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures

1 reference

12 December 2020

Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity.

1 reference

12 December 2020

Activated microglia mediate neuronal cell injury via a nitric oxide mechanism

1 reference

12 December 2020

Inflammatory signals induce neurotrophin expression in human microglial cells

1 reference

12 December 2020